The Inside Story Of Biotech’s Barnum And His Covid Cures

United States News News

The Inside Story Of Biotech’s Barnum And His Covid Cures
United States Latest News,United States Headlines
  • 📰 Forbes
  • ⏱ Reading Time:
  • 86 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 38%
  • Publisher: 53%

The inside story of biotech’s Barnum and his Covid cures by TheAlexKnapp

Billionaire Patrick Soon-Shiong’s radical cancer treatments made him one of the wealthiest physicians on Earth. Now the master of medical marketing believes his drug therapies could defeat “the crisis of our time.”when he realized that the Covid-19 pandemic was going to pose a serious threat. It was February 24, and the part-owner of the L.A. Lakers was at the Staples Center in Los Angeles for Kobe Bryant’s memorial service.

It’s an enormously ambitious plan from a man who has often been accused of being a hype artist. In an earlier incarnation, Soon-Shiong was a respected surgeon and professor at UCLA Medical School, but throughout his wildly successful entrepreneurial second act, he has been derided as more showman than scientist, thought guilty of overinflating results and taking undue credit.

Such interdisciplinary thinking may be what led to the medicine that made his fortune: Abraxane, which took an existing chemotherapy drug, Toxol, but wrapped it in protein that made it easier to deliver to tumors. It’s now used to treat advanced cases of lung, breast and pancreatic cancer. In 1998, to develop Abraxane, he purchased Fujisawa, a small, publicly traded business that sold injectable generic drugs. Soon-Shiong used its revenues to quickly move Abraxane through the regulatory process.

Other types of immunotherapies followed, ranging from purified antibodies that attack cancer to drugs that turn off the chemical switches that let tumor cells hide from the immune system. The latest advances involve CAR-T cell therapy, which first gained FDA approval in 2017 and involves genetically engineering immune cells from patients so that they attack certain targets found in tumor cells.

Former Senator Harry Reid, pictured the same month he began treatment for pancreatic cancer with Soon-Shiong, says being in remission a few months later was “kind of like a miracle.”Reid’s is an extraordinary story, as pancreatic cancer remains one of the deadliest forms of the disease. Within five years of diagnosis, it kills some 90% of patients, accounting for 7% of cancer deaths globally.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Forbes /  🏆 394. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

‘It’s been Covid, Covid, Covid’: Pro-Trump super PAC plans ad blitz on the economy‘It’s been Covid, Covid, Covid’: Pro-Trump super PAC plans ad blitz on the economyAmericans are still grappling with a global pandemic that has claimed nearly 180,000 lives in the U.S. alone. But America First Action, the largest super PAC supporting President Donald Trump’s reelection, is about to go all-in on the economy.
Read more »

'Disaster inside a disaster': California wildfires and COVID-19 form twin crises'Disaster inside a disaster': California wildfires and COVID-19 form twin crisesThe California LNU Lightning Complex fire has claimed the lives of at least 5 people, burned more than 350K acres and forced thousands to flee their homes.
Read more »

Limited legal protection for COVID vaccine makers hampers EU dealsLimited legal protection for COVID vaccine makers hampers EU dealsThe European Union is offering only partial protection to vaccine makers against legal risks from side-effects of their potential COVID-19 shots, European officials said, in a move that is hampering deals and contrasts with U.S. policy.
Read more »

Kazakhstan secures supplies of Russian COVID-19 vaccine candidateKazakhstan secures supplies of Russian COVID-19 vaccine candidateKazakhstan has signed a deal to get supplies of Russia's first potential COVID-19 vaccine once clinical trials are complete, the Central Asian nation's government and the backers of the Russian project said on Wednesday.
Read more »

Coronavirus Today: The COVID bluesCoronavirus Today: The COVID bluesOur special-edition newsletter breaks down the latest coronavirus news, including the severe impact the pandemic is having on Californians' mental health.
Read more »



Render Time: 2025-02-24 08:18:39